BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2737629
Number of visits today
1033
Number of downloads
2008993
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Ma K, Chen X, Liu W, Chen S, Yang C, Yang J. CTSB is a negative prognostic biomarker and therapeutic target associated with immune cells infiltration and immunosuppression in gliomas. Sci Rep 2022;12:4295. [PMID: 35277559 DOI: 10.1038/s41598-022-08346-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Jorfi M, Maaser-Hecker A, Tanzi RE. The neuroimmune axis of Alzheimer's disease. Genome Med 2023;15:6. [PMID: 36703235 DOI: 10.1186/s13073-023-01155-w] [Reference Citation Analysis]
2 Zamyatnin AA Jr, Gregory LC, Townsend PA, Soond SM. Beyond basic research: the contribution of cathepsin B to cancer development, diagnosis and therapy. Expert Opin Ther Targets 2022;26:963-77. [PMID: 36562407 DOI: 10.1080/14728222.2022.2161888] [Reference Citation Analysis]
3 Ma K, Chen S, Chen X, Yang C, Yang J. S100A10 Is a New Prognostic Biomarker Related to the Malignant Molecular Features and Immunosuppression Process of Adult Gliomas. World Neurosurg 2022;165:e650-63. [PMID: 35779750 DOI: 10.1016/j.wneu.2022.06.124] [Reference Citation Analysis]
4 Ma K, Chen S, Chen X, Zhao X, Yang J. CD93 is Associated with Glioma-related Malignant Processes and Immunosuppressive Cell Infiltration as an Inspiring Biomarker of Survivance. J Mol Neurosci 2022. [PMID: 36006582 DOI: 10.1007/s12031-022-02060-4] [Reference Citation Analysis]
5 Laurentino TDS, Soares RDS, Marie SKN, Oba-shinjo SM. Correlation of Matrisome-Associatted Gene Expressions with LOX Family Members in Astrocytomas Stratified by IDH Mutation Status. IJMS 2022;23:9507. [DOI: 10.3390/ijms23179507] [Reference Citation Analysis]
6 Ma K, Chen X, Zhao X, Chen S, Yang J. PLVAP is associated with glioma-associated malignant processes and immunosuppressive cell infiltration as a promising marker for prognosis. Heliyon 2022;8:e10298. [PMID: 36033326 DOI: 10.1016/j.heliyon.2022.e10298] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345